Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-20-043371

Options or other derivatives

  • Director acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sazdanoff Catherine · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-12-16 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +7,000 7,000 D
2020-12-16 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +11,000 11,000 D
Loading xslF345X03/ownership.xml…